GlassScriptPhysician profile
Minal Patel
NPI 1851819742
$4,160.79
in general payments reported to CMS, 2019-2025
26 companies · $917 in 2025
The $917 reported for 2025 was more than what 96% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $416 · 2022: $771 · 2023: $818 · 2024: $1,239 · 2025: $917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,974.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $694.07 | 2023-2025 | Ycanth |
| Alk-Abello, INC | $374.22 | 2023-2024 | Grastek, Odactra |
| Ultragenyx Pharmaceutical INC. | $323.07 | 2022-2023 | Crysvita |
| Phadia US INC. | $313.11 | 2021-2025 | Immunocap |
| Abbott Laboratories | $266.82 | 2022-2024 | Freestyle Libre 3 |
| Genzyme Corporation | $265.68 | 2024-2025 | |
| Cranial Technologies, INC | $198.51 | 2022-2025 | Doc Band |
| Kowa Pharmaceuticals America, INC. | $168.59 | 2025 | Zoryve |
| Glaxosmithkline, LLC. | $163.78 | 2022-2025 | Bexsero, Rotarix |
| Seqirus USA INC | $157.94 | 2023-2025 | Flucelvax |
| Sanofi-Aventis U.S. LLC | $156.96 | 2024-2025 | |
| Incyte Corporation | $125.00 | 2021 | |
| Supernus Pharmaceuticals, INC. | $124.99 | 2021 | |
| Abbvie INC. | $124.99 | 2025 | |
| Nestle Healthcare Nutrition INC. | $104.66 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $95.42 | 2022 | |
| Biomerieux INC | $79.13 | 2023 | |
| Pfizer INC. | $77.53 | 2023 | |
| Ironshore Pharmaceuticals INC. | $77.05 | 2023 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $67.48 | 2022 | |
| Sanofi Pasteur INC. | $52.96 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $46.27 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $33.51 | 2021 | |
| Corium, LLC | $26.55 | 2023 | Azstarys |
| Collegium Pharmaceutical, INC. | $22.16 | 2025 | Jornay Pm |
| Lnhc, INC | $20.34 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.